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PURPOSE: Transanal advancement flap repair (TAFR) has
been advocated as the treatment of choice for transsphinc-
teric fistulas passing through the upper or middle third of
the external anal sphincter. It is not clear whether previous
attempts at repair adversely affect the outcome of TAFR.
The purpose of the present study was to evaluate the
success rate of a repeat TAFR and to assess the impact of
such a second procedure on the overall healing rate of high
transsphinctericfistulasandonfecalcontinence. METHODS:
Between January 2001 and January 2005, a consecutive
series of 87 patients (62 males; median age, 49 (range, 27–
73) years) underwent TAFR. Median follow-up was 15
(range, 2–50) months. Patients in whom the initial
operation failed were offered two further treatment options:
a second flap repair or a long-term indwelling seton
drainage. Twenty-six patients (male:female ratio, 5:2; medi-
an age, 51 (range, 31–72) years) preferred a repeat repair.
Continence status was evaluated before and after the
procedures by using the Rockwood Faecal Incontinence
Severity Index (RFISI). RESULTS: The healing rate after the
first TAFR was 67 percent. Of the 29 patients in whom
the initial procedure failed, 26 underwent a repeat TAFR.
The healing rate after this second procedure was 69
percent, resulting in an overall success rate of 90 percent.
Both before and after the first attempt of TAFR, the median
RFISI was 7 (range, 0–34). In patients who underwent a
second TAFR, the median RFISI before and after this
procedure was 9 (range, 0–34) and 8 (range, 0–34),
respectively. None of these changes were statistically
significant. CONCLUSIONS: Repeat TAFR increases the
overall healing rate of high transsphincteric fistulas from
67 percent after one attempt to 90 percent after two
attempts without a deteriorating effect on fecal continence.
[Key words: Transsphincteric fistula; Transanal advance-
ment flap repair; Repeat repair; Fecal incontinence]
T
ransanal advancement flap repair (TAFR) has
been advocated as the treatment of choice for
transsphincteric perianal fistulas passing through the
upper or middle third of the external anal sphincter.
Initially, the reported healing rates varied between 84
and 100 percent.
1–4 In a recent study among 105
patients, conducted in two tertiary referral centers, a
healing rate of 69 percent was found.
5 Similar results
were reported by other authors.
6–9 It is still unclear
whether the outcome after TAFR is influenced by
previous attempts at repair. According to some
authors, previous procedures, such as fistulotomy,
fistulectomy, and the use of fibrin glue, adversely
affect the healing rate after TAFR.
6,10 However, these
findings could not be confirmed by others.
7,11 Until
now, data regarding the healing rate after repeat flap
repairs and their impact on fecal continence have
been scarce. It has been suggested that one single
TAFR may result in incontinence. The reported
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1508incidence of this side effect varies between 8 and
35 percent.
2,6,7,10–12 According to some authors,
inclusion of internal anal sphincter fibers, which is
necessary to strengthen the flap, contributes to the
impairment of continence. Based on this assumption
it might be possible that a second flap repair further
deteriorates fecal incontinence. This study was
designed to investigate the healing rate after a repeat
flap repair and to assess the impact of such a second
procedure on the overall healing rate of high trans-
sphincteric fistulas. In addition, fecal continence was
assessed before and after the first and second flap
repair, using the Rockwood Fecal Incontinence
Severity Index (RFISI).
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PATIENTS AND METHODS
Between January 2001 and January 2005, a con-
secutive series of 87 patients (62 males) with a
transsphincteric fistula of cryptoglandular origin,
passing through the middle or upper third of the
external anal sphincter, underwent TAFR. Median
age at the time of repair was 49 (range, 27–73) years.
Before the procedure, all patients underwent endoa-
nal magnetic resonance imaging (MRI) to confirm the
transsphincteric course of the fistulous track. This
imaging technique also was performed to identify the
location of the internal opening and to detect the
presence of any horseshoe extensions. This first
attempt at repair failed in 29 patients (33 percent).
These subjects were offered two further treatment
options: a second flap repair, or a long-term indwell-
ing seton drainage. Twenty-six patients (male:female
ratio 5:2; median age, 51 (range, 31–72) years)
preferred a repeat repair. Three patients were treated
by the loose-seton technique. This loose-fitting seton
is left in situ for at least three to four years. In our
experience, the seton slowly migrates through the
external sphincter. When it reaches the subcutaneous
level, it is removed and the remnant of the fistulous
tract is excised.
Surgical Technique
Patients underwent complete mechanical bowel
preparation (polyethylene glycol). After induction of
general endotracheal anesthesia, metronidazole
(500 mg) together with cefuroxime (1,500 mg) was
administered intravenously. With the patient in prone
jackknife position, the internal opening of the fistula
was exposed by using a Lone Star retractor (Lone Star
Retractor System
\, Lone Star Medical Products, Inc.,
Houston, TX). The crypt-bearing tissue around the
internal opening, as well as the overlying anodermis
was then excised. The fistulous tract was cored out of
the sphincters. The defect in the internal anal
sphincter was closed with absorbable sutures. A
flap consisting of mucosa, submucosa, and some of
the most superficial fibers of the internal anal
sphincter was raised from the level of the dentate
line and mobilized over a distance of 4 to 6 cm
proximally. The base of flap was approximately
twice the width of its apex. The flap was advanced
and sutured to the neodentate line with absorbable
sutures. One surgeon performed all operations.
Exactly the same surgical technique was used in
both the first and the second repair.
Postoperative Care
All patients were immobilized for five days. During
these five days, a Foley catheter was given to obtain
complete bed rest. All patients received a clear liquid
diet for five days. During this time period, metroni-
dazole and cefuroxime were administered intrave-
nously three times daily. Average duration of hospital
stay was seven days.
Assessment of Fecal Continence
Impairment of continence was evaluated both
before and after the first and second attempt by
using the Rockwood Fecal Incontinence Severity
Index (RFISI). This is a validated index based on a
type X frequency matrix. The matrix includes four
types of leakage commonly found in the fecal
incontinent population: gas, mucus, liquid, and solid
stools; and five frequencies: once to three times per
month, once per week, twice per week, once per
day, and twice per day. For the specification of the
weighting scores, patient input was used. Scores
range from zero (total continence) to 61 (complete
incontinence to solid stool on daily bases).
For statistical analysis, the Fisher’s exact test was
used. P value < 0.05 was considered to be statistically
significant.
RESULTS
Median duration of follow-up was 15 (range, 2–
50) months. Fistula healing was observed in 58 of
87 patients (67 percent). Of the 29 patients in
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repeat TAFR. The healing rate after this second
procedure was 69 percent, resulting in an overall
success rate of 90 percent.
Before the first attempt at TAFR, the median RFISI
was 7 (range, 0–34). The median score did not
change after the first procedure. In three of these
patients the RFISI improved, and in three patients it
worsened. In all other patients, RFISI did not change
after the first procedure. Before and after the second
repair, the median RFISI was 9 (range, 0–34) and
8 (range, 0–34), respectively. This change was not
statistically significant. In 1 of these patients, the
RFISI improved, in 1 it worsened, and in 24 patients
RFISI did not change after the second procedure.
Of the eight patients in whom the second flap
repair failed, one patient was successfully treated
with anocutaneous advancement flap repair. The
other seven patients were treated with long-term
indwelling seton drainage (Table 1).
DISCUSSION
Transanal advancement flap repair has been
advocated as the treatment of choice for transsphinc-
teric perianal fistulas passing through the upper or
middle third of the external anal sphincter. Initially,
healing rates between 84 and 100 percent were
reported.
1–4 During the last decade, several studies
have revealed considerably higher recurrence
rates.
5–8,10,14 In a Dutch study among 105 patients,
conducted in two tertiary referral centers, a recur-
rence rate of 31 percent was observed.
5 Similar
results have been reported by other investiga-
tors.
6–8,10,14 There is some evidence that previous
attempts at repair are a negative predictor of
outcome. A previous study, conducted at our own
institution, revealed a less favorable outcome in
patients who had undergone two or more previous
attempts at repair, such as fistulotomy or fistulec-
tomy.
10 In 44 patients who underwent a flap repair,
we found that the healing rate was 87 percent in
patients who had undergone no or only one
previous attempt at repair. This healing rate dropped
to 50 percent in patients who had undergone two or
more previous attempts at repair. A similar finding
was observed by Ozuner and coworkers.
6 According
to others, however, the number of previous repair
does not affect the outcome of TAFR.
7,8,11
Until now data regarding the healing rate after
repeat flap repairs and their impact on fecal conti-
nence have been scarce. According to Lindsey
et al.,
15 the efficacy of a repeat TAFR is limited
because Bthe scarring associated with a failed advance-
ment flap compromises the changes of success with
subsequent flaps.^ In a study conducted by Kodner
et al.,
4 nine patients in whom the initial flap repair
failed underwent a second operation, which was
successful in all patients. In a study conducted by
Mizrahi et al.,
7 12 patients underwent repeat surgery
because of initial failure, of whom 8 healed (67
percent). These two small series indicate that a repeat
flap repair might be worthwhile. However, the impact
on fecal continence was not assessed in these two
studies. The data obtained from our present study are
in accordance with those reported by Kodner et al.
and Mizrahi et al. The healing rate of the second
procedure was 69 percent. This successful outcome
resulted in an overall healing rate of 90 percent. We do
not know which factors are predictors of outcome and
why flaps that initially failed did succeed on the
second repair. We choose to report this data after a
median follow-up of 15 months. Although this time
period might seem relatively short, there are indicators
that more than 80 percent of the recurrences are within
the first 12 months.
6
In a study conducted by Athanasiadis et al., 90
percent of recurrent fistulas developed within the
first year after treatment.
16 The reported incidence of
disturbed continence after TAFR varied between
8 and 35 percent.
2,4,5,7,10,11 It has been postulated
that the inclusion of internal anal sphincter fibers,
Table 1.
Results of Repeat TAFR
No. of
Patients
Median
Follow-Up (mo)
Healing
Rate (%)
Median
RFISI Before
Median
RFISI After
First repair 87 15 67 7 7
Second repair 26 15 69 9 8
After two repairs 87 15 90 8 8
TAFR=transanal advancement flap repair; RFISI=Rockwood Fecal Incontinence Severity Index.
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to the impairment of continence.
17 A second flap also
requires inclusion of internal anal sphincter fibers,
which might result in further impairment of fecal
continence. In a previous study, we were able to
demonstrate that the use of a Parks retractor has a
deteriorating effect on fecal continence. This side
effect was not observed after flap repair with the use
of a Lone Star retractor.
18 In the present study, this
ring retractor, with multiple skin hooks on elastic
bands, was used to gain access to the anal canal.
Although internal anal sphincter fibers were in-
cluded to strengthen the second flap, no deteriora-
tion of continence was observed after the repeat flap
repair. Therefore, it seems unlikely that inclusion of
internal anal sphincter fibers contributes to the
impairment of fecal continence after transanal ad-
vancement flap repair. In our opinion, avoidance of
anal stretch during the procedure is far more
important in reducing the risk of postoperative
continence disturbances. The median postoperative
RFISI score observed in our patients was 8. It seems
likely that this minor deterioration of continence did
not affect the quality of life of our patients, because it
has been reported that only a score > 30 has a
detrimental effect on quality of life.
19
Based on the data obtained from the present study,
it is recommended to offer all patients a repeat TAFR
after a failed first flap repair.
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